Saturday 10 October 2026 · Edition of the day

Current editionPast editions →

The Skeptic's Daily

The day's biggest stories, taken apart. For each one: what is actually established, what is only asserted, the questions worth asking — and a plausibility score for the central claim, given everything currently known.

Stories
3
Average plausibility
71%
How to read the score
It rates how well the core claim is evidenced — not how important the story is, nor whether it is good or bad news.
RegionAllGlobalAfricaNorth AmericaSouth AmericaAsia-PacificEuropeMiddle East
TopicAllPoliticsConflict & SecurityBusinessScienceHealth
01HealthEurope

Government review warns of possible ADHD and autism over-diagnosis

The review focuses on younger people, but the supplied coverage does not establish how often diagnoses may be inappropriate.

The BBC reports that a government review warned of a risk of moving from under-diagnosis to over-diagnosis of ADHD and autism. The review focuses on younger people. A related BBC explainer describes implications for the NHS, welfare, education and employment policies.

What holds up

  • ✓Two BBC items cover the review, with one reporting its diagnostic warning and the other outlining policy implications.
  • ✓The warning is framed as a risk, not a demonstrated rate of over-diagnosis.

What doesn't yet

  • ?Both items are from the BBC; neither supplied extract provides the review's methods, data or diagnostic criteria.
  • ?The summaries do not quantify over-diagnosis or establish that it has replaced under-diagnosis.

Ask before you share

  • →What evidence and criteria does the review use to assess inappropriate diagnosis?
  • →How does it distinguish over-diagnosis from improved recognition of previously unmet needs?

Sources & original reporting

  1. [1]BBC News · Published 9 Oct 2026 · bbc.co.uk
  2. [2]BBC News · Published 8 Oct 2026 · bbc.co.uk
02HealthAfrica

Guinea-Bissau vaccine trial receives approval, Guardian reports

The reported study would withhold a recommended hepatitis B vaccine dose from thousands of newborns.

The Guardian reports that a controversial vaccine trial in Guinea-Bissau received approval to proceed this week. The supplied excerpt says Danish researchers will withhold a recommended hepatitis B vaccine dose from thousands of newborns. It also describes the trial as promoted by Robert F Kennedy Jr.

What holds up

  • ✓The Guardian explicitly reports approval for the trial to proceed.
  • ✓Its excerpt identifies Danish researchers and the withholding of a recommended hepatitis B vaccine dose.

What doesn't yet

  • ?The excerpt does not identify the approving authority or supply the trial protocol and ethics decision.
  • ?The exact enrolment, consent arrangements and researchers' rationale are absent; the supplied article text is truncated.

Ask before you share

  • →Which authorities approved the trial, and is the protocol publicly available?
  • →What are the consent procedures, safeguards and scientific justification for withholding the dose?

Sources & original reporting

  1. [1]The Guardian · Published 9 Oct 2026 · theguardian.com
03HealthAsia-Pacific

Australian advocates seek subsidised weight-loss drugs for women with PMOS

The Guardian reports an access campaign alongside off-label prescribing of GLP-1 medicines.

Australian advocates say women with PMOS should receive subsidised weight-loss drugs, the Guardian reports. Its summary says GLP-1 medicines are being prescribed off-label because they are not specifically approved by the TGA to treat the condition.

What holds up

  • ✓The item reports an advocacy demand, not an announced subsidy decision.
  • ✓The summary explicitly distinguishes off-label prescribing from specific TGA approval for the condition.

What doesn't yet

  • ?The supplied extract does not identify the advocates or provide evidence of treatment benefits and risks.
  • ?It gives no patient numbers, costs or regulator response, and does not expand the term PMOS.

Ask before you share

  • →What clinical evidence supports these medicines for the condition?
  • →What eligibility, costs and safeguards would the proposed subsidy involve?

Sources & original reporting

  1. [1]The Guardian · Published 9 Oct 2026 · theguardian.com